BeyondSpring Provides Business Update and Reports Year End 2

18.04.2023 - - SEED Therapeutics, a BeyondSpring Subsidiary, Achieved Milestones on the Eli Lilly Collaboration - BeyondSpring Completed Enrollment of Three Investigator-Initiated Trials (IIT) with Plinabulin in the U.S. for Multiple Cancer Indications NEW ...

Related Keywords

New York , United States , China , American , Sloan Kettering , Eli Lilly , Bristol Myers Squibb Opdivo , Sasia Congress , Beyondspring Inc , Md Anderson Cancer Center , Nasdaq , Exchange Commission , Memorial Sloan Kettering Cancer Center , China National Medical Products Administration , American Society Of Hematology , European Society For Medical Oncology , Alan Huang , Memorial Sloan Kettering , National Medical Products Administration , American Society , Annual Meeting , European Society , Medical Oncology , San Antonio Breast Cancer Symposium , Bristol Myers Squibb , Patient Enrollment , Plinabulin Combined , Topline Data Readout , New York City ,